Search





Search





Markets
/
Stocks
/
pcvx
/

Vaxcyte Inc

PCVX

Add to Watchlist

54.080USD

-1.880-3.36%

Close 07-31 16:00（ET）Quotes delayed by 15 min

7.80BMarket Cap

LossP/E TTM

Vaxcyte Inc

54.080

-1.880-3.36%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

PCVX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Vaxcyte Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q2

FY2019Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-68.77%-280.63M

-101.82%-224.83M

-136.06%-143.31M

0.19%-121.17M

-4.49%-166.27M

13.52%-111.40M

-5.49%-60.71M

-93.48%-121.39M

-233.66%-159.12M

-97.50%-128.81M

-49.29%-57.55M

-60.36%-62.74M

-72.15%-47.69M

-27.65%-65.22M

-35.66%-38.55M

-36.42%-39.13M

-109.78%-27.70M

-374.49%-51.09M

-117.66%-28.41M

-212.69%-28.68M

3.14%-13.21M

---10.77M

---13.05M

32.12%-9.17M

-39.57%-13.63M

---13.51M

---9.77M

Net income from continuing operations

-127.85%-320.62M

-79.83%-246.51M

-106.38%-212.83M

-29.42%-166.57M

-48.09%-140.72M

24.18%-137.08M

-11.29%-103.12M

-88.33%-128.70M

-57.16%-95.02M

-131.65%-180.80M

-59.99%-92.66M

-40.81%-68.34M

-55.09%-60.46M

-173.26%-78.05M

-117.61%-57.92M

-104.96%-48.53M

-83.72%-38.99M

-37.74%-28.56M

-26.63%-26.61M

-16.53%-23.68M

21.82%-21.22M

---20.74M

---21.02M

-90.53%-20.32M

-98.54%-27.14M

---10.66M

---13.67M

Operating gains losses

-0.30%2.95M

161.77%7.50M

71.36%3.06M

112.94%2.88M

195.90%2.96M

222.52%2.86M

121.84%1.79M

80.27%1.35M

40.31%999.00K

26.50%888.00K

17.84%806.00K

-1.96%750.00K

11.42%712.00K

52.94%702.00K

34.12%684.00K

58.06%765.00K

84.15%639.00K

38.25%459.00K

52.69%510.00K

-22.19%484.00K

-9.64%347.00K

--332.00K

--334.00K

105.96%622.00K

30.61%384.00K

--302.00K

--294.00K

Other non-cash items

93.16%-205.00K

95.27%-461.00K

96.15%-131.00K

69.48%-2.38M

66.34%-3.00M

-3056.96%-9.76M

73.64%-3.40M

23.40%-7.81M

-104.11%-8.90M

-103.67%-309.00K

-1000.70%-12.90M

-696.43%-10.19M

-306.83%-4.36M

577.23%8.42M

84.77%1.43M

139.36%1.71M

536.86%2.11M

--1.24M

--775.00K

--714.00K

84.92%331.00K

--0.00

100.00%0.00

6066.67%179.00K

---1.68M

---3.00K

Change in working capital

94.12%-2.91M

-692.88%-19.70M

9.79%32.08M

532.32%33.69M

32.94%-49.52M

-106.53%-2.48M

-14.04%29.22M

-412.22%-7.79M

-1190.27%-73.83M

1253.45%38.06M

220.49%33.99M

140.46%2.50M

54.12%6.77M

87.98%-3.30M

275.17%10.61M

111.57%1.04M

-19.70%4.39M

-456.56%-27.45M

-204.83%-6.05M

-197.26%-8.97M

-56.48%5.47M

--7.70M

--5.78M

567.36%9.22M

252.02%12.57M

---1.97M

--3.57M

-Change in prepaid expenses

-483.26%-8.74M

-189.63%-9.55M

261.66%915.00K

-322.68%-6.67M

69.77%-1.50M

-121.36%-3.30M

-107.94%-566.00K

33166.67%2.99M

-5.44%-4.96M

738.24%15.44M

289.29%7.12M

100.51%9.00K

-268.47%-4.70M

-127.07%-2.42M

118.42%1.83M

69.57%-1.77M

601.08%2.79M

810.08%8.94M

-1180.41%-9.94M

-946.14%-5.81M

41.43%-557.00K

--982.00K

---776.00K

430.29%687.00K

-65.97%-951.00K

---208.00K

---573.00K

-Change in other current assets

30.06%-16.88M

6.93%-46.34M

2.02%-11.32M

-60.05%-10.48M

-181.19%-24.13M

2.57%-49.78M

-4138.11%-11.55M

-1516.88%-6.55M

-1495.28%-8.58M

-74149.28%-51.09M

-64.34%286.00K

91.70%462.00K

139.00%615.00K

113.56%69.00K

126.09%802.00K

-50.31%241.00K

-257.60%-1.58M

-371.30%-509.00K

-27845.45%-3.07M

264.66%485.00K

-395.51%-441.00K

---108.00K

---11.00K

156.36%133.00K

-178.07%-89.00K

---236.00K

--114.00K

-Change in other current liabilities

----

100.00%0.00

----

---3.00K

---5.00K

-101.28%-1.00K

---2.00K

--78.00K

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-68.77%-280.63M

-101.82%-224.83M

-136.06%-143.31M

0.19%-121.17M

-4.49%-166.27M

13.52%-111.40M

-5.49%-60.71M

-93.48%-121.39M

-233.66%-159.12M

-97.50%-128.81M

-49.29%-57.55M

-60.36%-62.74M

-72.15%-47.69M

-27.65%-65.22M

-35.66%-38.55M

-36.42%-39.13M

-109.78%-27.70M

-374.49%-51.09M

-117.66%-28.41M

-212.69%-28.68M

3.14%-13.21M

---10.77M

---13.05M

32.12%-9.17M

-39.57%-13.63M

---13.51M

---9.77M

Investing cash flow

Net cash from continuing investing activities

-44.70%14.79M

-71.96%8.42M

-68.37%12.05M

-74.97%9.76M

121.60%26.75M

-47.38%30.03M

418.87%38.08M

1921.50%38.98M

115.23%12.07M

4875.50%57.07M

770.58%7.34M

-328.14%-2.14M

92.55%5.61M

-15.41%1.15M

-50.96%843.00K

-57.52%938.00K

133.79%2.91M

87.81%1.36M

8285.71%1.72M

3914.55%2.21M

257.02%1.25M

--722.00K

---21.00K

-66.87%55.00K

2081.25%349.00K

--166.00K

--16.00K

Capital expenditures

-44.70%14.79M

-71.96%8.42M

-68.37%12.05M

-74.97%9.76M

121.60%26.75M

-47.38%30.03M

418.87%38.08M

--38.98M

115.23%12.07M

4875.50%57.07M

770.58%7.34M

----

92.09%5.61M

-17.00%1.15M

-50.96%843.00K

-57.52%938.00K

134.35%2.92M

91.41%1.38M

5827.59%1.72M

3914.55%2.21M

257.02%1.25M

--722.00K

--29.00K

-66.87%55.00K

2081.25%349.00K

--166.00K

--16.00K

Net cash flow from disposal of fixed assets

-44.70%14.79M

-71.96%8.42M

-68.37%12.05M

-74.97%9.76M

121.60%26.75M

-47.38%30.03M

418.87%38.08M

1921.50%38.98M

115.23%12.07M

4875.50%57.07M

770.58%7.34M

-328.14%-2.14M

92.55%5.61M

-15.41%1.15M

-50.96%843.00K

-57.52%938.00K

133.79%2.91M

87.81%1.36M

8285.71%1.72M

3914.55%2.21M

257.02%1.25M

--722.00K

---21.00K

-66.87%55.00K

2081.25%349.00K

--166.00K

--16.00K

Net cash flow from investment products

-245.68%-218.62M

123.44%123.55M

115.16%133.22M

311.21%87.50M

134.18%150.07M

-1321.85%-527.14M

-3067.48%-878.94M

87.66%-41.43M

0.79%-439.00M

223.96%43.14M

-16.68%29.62M

-1338.62%-335.70M

-941.58%-442.49M

-2520.38%-34.80M

312.23%35.55M

247.93%27.10M

130.54%52.58M

--1.44M

---16.75M

---18.32M

---172.15M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-289.28%-233.41M

120.66%115.13M

113.21%121.17M

196.69%77.74M

127.34%123.32M

-3900.92%-557.17M

-4215.88%-917.02M

75.89%-80.41M

-0.66%-451.07M

61.27%-13.93M

-35.80%22.28M

-1374.85%-333.56M

-1002.23%-448.10M

-43943.90%-35.95M

287.91%34.71M

227.45%26.16M

128.64%49.67M

111.36%82.00K

-88047.62%-18.47M

-37227.27%-20.53M

-49582.23%-173.39M

---722.00K

--21.00K

66.87%-55.00K

-2081.25%-349.00K

---166.00K

---16.00K

Financing cash flow

Cash flow from continuous financing activities

79159.95%601.58M

-50.93%2.41M

-100.24%-3.67M

-97.72%2.52M

-99.91%759.00K

79.41%4.91M

3020.57%1.52B

-79.82%110.37M

1868.62%818.20M

-99.58%2.73M

10.30%48.55M

996.61%546.97M

-62.56%41.56M

7400.95%656.63M

479.25%44.02M

5117.36%49.88M

22696.51%111.02M

1477.30%8.75M

21008.33%7.60M

-99.64%956.00K

-99.56%487.00K

--555.00K

--36.00K

343583.12%264.48M

144569.74%109.80M

---77.00K

---76.00K

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

--0.00

98.73%-1.00K

21.05%-60.00K

---79.00K

---76.00K

Net cash flow from common stock issuance/repurchase

----

--0.00

-100.00%0.00

----

82.57%89.46M

--106.51M

-100.00%0.00

-100.00%-23.00K

13.63%49.00M

-100.00%0.00

1241.48%41.79M

11114.53%761.24M

506.65%43.12M

--49.00M

--3.12M

--6.79M

--7.11M

-100.00%0.00

--0.00

--267.38M

--36.00K

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--4.00K

--109.88M

----

Proceeds from stock option exercised by employees

49.31%9.03M

-43.01%3.42M

-97.39%306.00K

-26.46%3.23M

20.40%6.05M

94.04%5.99M

444.64%11.74M

131.40%4.40M

900.80%5.02M

2.42%3.09M

22.65%2.15M

117.51%1.90M

78.01%502.00K

53.36%3.02M

257.84%1.76M

-8.58%874.00K

-42.09%282.00K

254.23%1.97M

354.63%491.00K

221.89%956.00K

893.88%487.00K

--555.00K

--108.00K

14750.00%297.00K

--49.00K

--2.00K

----

Net cash flow from other financing activities

11301.34%592.55M

7.19%-1.01M

-100.28%-3.98M

-32.78%-717.00K

-100.65%-5.29M

-228.79%-1.08M

54374.09%1.41B

-100.10%-540.00K

111953.09%813.17M

99.69%-330.00K

-202.56%-2.60M

27253150.00%545.07M

-100.68%-727.00K

---107.62M

---861.00K

--2.00K

--107.62M

--0.00

100.00%0.00

--0.00

---72.00K

---3.19M

---103.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

79159.95%601.58M

-50.93%2.41M

-100.24%-3.67M

-97.72%2.52M

-99.91%759.00K

79.41%4.91M

3020.57%1.52B

-79.82%110.37M

1868.62%818.20M

-99.58%2.73M

10.30%48.55M

996.61%546.97M

-62.56%41.56M

7400.95%656.63M

479.25%44.02M

5117.36%49.88M

22696.51%111.02M

1477.30%8.75M

21008.33%7.60M

-99.64%956.00K

-99.56%487.00K

--555.00K

--36.00K

343583.12%264.48M

144569.74%109.80M

---77.00K

---76.00K

Net cash flow

Beginning cash balance

-54.93%175.43M

-73.13%282.55M

-40.73%308.06M

-43.17%348.17M

-2.35%389.19M

92.50%1.05B

-2.28%519.77M

60.66%612.62M

-52.30%398.55M

95.59%546.24M

122.51%531.90M

88.20%381.32M

1096.07%835.53M

147.33%279.27M

57.40%239.04M

1.40%202.61M

-81.91%69.86M

-71.56%112.92M

-62.96%151.87M

29.08%199.81M

554.84%386.20M

--397.05M

--410.05M

175.28%154.79M

-10.76%58.98M

--56.23M

--66.09M

Current period cash flow changes

311.78%86.88M

83.83%-107.12M

-104.80%-25.52M

56.80%-40.11M

-119.17%-41.03M

-348.47%-662.31M

3609.86%531.73M

-161.66%-92.84M

147.13%214.06M

-126.55%-147.68M

-64.37%14.33M

313.32%150.58M

-442.14%-454.21M

1391.85%556.26M

203.28%40.23M

175.99%36.43M

171.22%132.76M

-296.93%-43.06M

-199.68%-38.95M

-118.78%-47.94M

-294.53%-186.39M

---10.85M

---13.00M

1955.59%255.25M

1071.75%95.81M

---13.76M

---9.86M

Effect of exchange rate changes

-156.66%-664.00K

-86.96%176.00K

105.22%291.00K

156.74%800.00K

-80.67%1.17M

117.57%1.35M

-630.54%-5.58M

-1707.69%-1.41M

26256.52%6.06M

-1065.08%-7.68M

1883.02%1.05M

83.92%-78.00K

110.13%23.00K

199.25%796.00K

-84.08%53.00K

-255.95%-485.00K

19.22%-227.00K

-1021.84%-802.00K

--333.00K

--311.00K

---281.00K

--87.00K

----

Ending cash balance

-24.66%262.31M

-54.93%175.43M

-73.13%282.55M

-40.73%308.06M

-43.17%348.17M

-2.35%389.19M

92.50%1.05B

-2.28%519.77M

60.66%612.62M

-52.30%398.55M

95.59%546.24M

122.51%531.90M

88.20%381.32M

1096.07%835.53M

147.33%279.27M

57.40%239.04M

1.40%202.61M

-81.91%69.86M

-71.56%112.92M

-62.96%151.87M

29.08%199.81M

--386.20M

--397.05M

865.40%410.05M

175.28%154.79M

--42.47M

--56.23M

Free cash flow

-53.05%-295.42M

-64.93%-233.25M

-57.26%-155.35M

18.37%-130.92M

-12.75%-193.03M

23.91%-141.43M

-52.25%-98.79M

-155.61%-160.37M

-221.20%-171.20M

-180.07%-185.88M

-64.73%-64.89M

-56.60%-62.74M

-74.05%-53.30M

-26.48%-66.37M

-30.72%-39.39M

-29.71%-40.06M

-111.90%-30.62M

-356.70%-52.48M

-130.31%-30.13M

-234.76%-30.89M

-3.35%-14.45M

---11.49M

---13.08M

32.55%-9.23M

-42.91%-13.98M

---13.68M

---9.78M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Vaxcyte Inc Generate?



Vaxcyte Inc generated -655.58M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Vaxcyte Inc's Operating Cash Flow Change Year Over Year?



Vaxcyte Inc's operating cash flow increased by -44.84% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Vaxcyte Inc Spend on Capital Expenditures?



Vaxcyte Inc spent 56.97M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Vaxcyte Inc's Financing Cash Flow Changed?



Vaxcyte Inc used 2.01M in financing activities in the latest quarter.

What is free cash flow and why does it matter for PCVX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Vaxcyte Inc’s free cash flow in the latest quarter?



Free cash flow was -712.55M reflecting a -24.62% change from the previous year.